Every TITN device is mapped to its FDA regulatory tier, its CMS-billable codes, and the peer-reviewed literature behind it. The 510(k) records, CPT and LCD references, and DOIs are all linked below. Credibility you can check, not claims you have to trust.
FDA 510(k) cleared aid-in-diagnosis EEG and event-related potential platform. Used for cognitive screening, concussion baseline and management, ADHD assessment, and longitudinal brain monitoring.
K213900 · WAVi SCAN software, indicated for acquisition, display, and storage of EEG and event-related potentials to aid in diagnosis.
95999 · Unlisted neurological or neuromuscular diagnostic procedure for an EEG plus ERP panel device, billed as one unit and not unbundled to component codes; unlisted codes are priced by report and confirmed with the payer before service99483 · Cognitive assessment and care plan visit (directional Medicare $260 to $282, once per 180 days)95816 routine EEG, 95957 digital EEG analysis, 95930 VEP) only where a separate test is independently performed, documented, and payer-recognizedRates per CMS Physician Fee Schedule. Verify locality via the CMS PFS Look-Up. Coverage and reimbursement vary by payer.
K162460 Research Desktop variant is not marketed.
Three-module integrated workstation, each module independently FDA 510(k) cleared. Manufactured by LD Technology. Covers autonomic function, sudomotor activity, and ankle-brachial index in one ten-minute session.
K173696 · Ankle-brachial index, pulse volume recording, plethysmography for PAD screening.
K200141 · SpO2, pulse rate, photoplethysmography waveform analysis, HRV, endothelial function analysis.
95921 · Cardiovagal innervation testing95922 · Vasomotor adrenergic testing95923 · Sudomotor (QSART, SSP) testing95924 · Combined parasympathetic / sympathetic with tilt93922 · Limited bilateral arterial physiologic studies93923 · Complete bilateral arterial physiologic studiesCoverage criteria per CMS LCD A57651 and A57551. Documentation must support medical necessity.
Pulse-wave cardiovascular and arterial stiffness screening at chairside. Three-to-five-minute test, immediate report.
Pulse-wave analysis as a vascular biomarker rests on a substantial peer-reviewed evidence base, independent of any single device. Aortic pulse wave velocity and augmentation index are well-characterized markers of arterial stiffness in the cardiology literature. We cite the device by its FDA 510(k) number (K110374) and do not claim device-specific validation studies beyond what the manufacturer or independent investigators have published.
FDA 510(k) cleared rTMS therapy for adults with Major Depressive Disorder who have failed prior antidepressants. Reimbursable through a full treatment course under TMS CPT codes.
K220625 · ALTMS / BLOSSOM TMS, repetitive transcranial magnetic stimulation indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode.
The Hue Light USA suite operates exclusively under the FDA General Wellness policy for low-risk devices. These products are not FDA cleared. The peer-reviewed citations below describe the underlying mechanism research for each modality; they are not Hue Light-specific clinical claims.
Clinical-grade genetic testing delivered by PreCheckHealth Services. Four provider-ordered panels covering pharmacogenomics, hereditary cancer, immunogenetics, and adult neurogenetics.
10D2210020 · Clinical Laboratory Improvement Amendments certified for high-complexity testing.
9101993 · College of American Pathologists accredited laboratory.
All four panels are provider-ordered through PreCheckHealth and delivered with virtual genetic counseling. PreCheckHealth bills insurance directly; TITN serves as a referral partner. The genetic data integrates with TITN's WAVi and TM-Flow records on the HIPAA-compliant patient portal.
Pharmacogenomics pairs cleanly with ALTMS treatment planning (psychiatric medication metabolism). The Neurogenetic Panel pairs with WAVi for genetic-plus-functional baseline assessment.
Every claim on this page traces to one of these source tiers. Estimates and "directional" data are marked. If a claim cannot trace to a source, it is not on this page.
FDA 510(k) database (accessdata.fda.gov), CMS Physician Fee Schedule (PFS Look-Up), CMS Coverage Database (LCDs, NCDs, articles), peer-reviewed citations via PubMed and DOI.
Device IFUs, manufacturer regulatory pages (LD Technology, WAVi Co, REMED), Hue Light USA technical specifications. Used for device specs, not for clinical efficacy claims.
The TITN Forbidden Claims sheet lives in our internal regulatory documentation. Highlights are surfaced under each device above. Examples: WAVi does not "diagnose" Alzheimer's, TM-Flow modules are cited individually by K-number rather than collapsed, Hue Light products operate exclusively under General Wellness scope.
Listed CPT codes and Medicare PFS rates are reference points only. Actual reimbursement varies by payer, plan, locality, and patient eligibility. CMS-published rates change annually. Verify locality-specific rates via the CMS PFS Look-Up before billing.
Live as of June 10, 2026. Next scheduled review: June 10, 2027. Spot a broken or outdated link? Email roberto@transitionitnow.com.
10D2210020 · College of American Pathologists accreditation 9101993 (verifiable via CMS CLIA Look-Up and CAP directory).Book a 15-minute call and we will walk through the evidence for the devices that fit your practice, with the reimbursement math worked out for your locality.
Book a 15-min call